According to FutureWise analysis, the mycoplasma plate antigens market in 2026 is US$0.62 billion, and is expected to reach US$1.09 billion by 2036 at a CAGR of 5.80%.  The Mycoplasma Plate Antigens market is experiencing significant growth, driven primarily by an alarming rise in mycoplasma-related respiratory infections. Among these, Mycoplasma pneumoniae stands out as a major...